{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:55Z","timestamp":1761129535969},"reference-count":19,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Malawi Liverpool Wellcome Trust Clinical Research Unit"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["061230"],"award-info":[{"award-number":["061230"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T21:51:30Z","timestamp":1523137890000},"page":"2504-2506","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi"],"prefix":"10.1016","volume":"36","author":[{"given":"A.B.","family":"Ibarz-Pavon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2018.04.009_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QCO.0b013e328012c5f1","article-title":"HIV and pneumococcal disease","volume":"20","author":"Klugman","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.04.009_b0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2018.04.009_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and\/or 23-valent polysaccharide vaccine among HIV-infected adults","volume":"20","author":"Feikin","year":"2001","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.009_b0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jfma.2011.06.027","article-title":"Impact of vaccination with seven-valent pneumococcal conjugate vaccine on virologic and immunologic outcomes among HIV-infected adult patients in the era of highly active antiretroviral therapy","volume":"111","author":"Lu","year":"2012","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.009_b0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/21645515.2015.1084450","article-title":"The potential impact of pneumococcal conjugate vaccine in Africa: considerations and early lessons learned from the South African experience","volume":"12","author":"Madhi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.04.009_b0030","first-page":"s2","article-title":"British HIV association guidelines on the use of vaccines in HIV-positive adults 2015","volume":"17","author":"Geretti","year":"2016","journal-title":"HIV Med"},{"issue":"25","key":"10.1016\/j.vaccine.2018.04.009_b0035","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6\u201318 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Centers for Disease C, Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"40","key":"10.1016\/j.vaccine.2018.04.009_b0040","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease C, Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.009_b0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1468-1293.2011.00961.x","article-title":"Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients","volume":"13","author":"Calmy","year":"2012","journal-title":"HIV Med"},{"issue":"19","key":"10.1016\/j.vaccine.2018.04.009_b0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199605093341916","article-title":"Hepatitis B vaccination and plasma HIV-1 RNA","volume":"334","author":"Cheeseman","year":"1996","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.vaccine.2018.04.009_b0055","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM199605093341903","article-title":"Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1","volume":"334","author":"Stanley","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.009_b0060","first-page":"1","article-title":"Influenza vaccination in HIV-positive subjects: latest evidence and future perspective","volume":"54","author":"Ceravolo","year":"2013","journal-title":"J Prev Med Hyg"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2018.04.009_b0065","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.vaccine.2003.10.030","article-title":"Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study","volume":"22","author":"Hung","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.009_b0070","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10096-002-0743-z","article-title":"Comparative trial of the effect of pneumococcal vaccine on viral load and CD4+ lymphocytes in asymptomatic and antiretrovirally naive HIV-infected patients","volume":"21","author":"Santos","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.009_b0075","first-page":"567","article-title":"Risks and benefits of influenza and pneumococcal immunization in HIV-1 infected individuals","volume":"15","author":"Tanzi","year":"2003","journal-title":"Ann Ig"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.009_b0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/174.6.1191","article-title":"Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine","volume":"174","author":"Brichacek","year":"1996","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.009_b0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00006454-200007000-00006","article-title":"Pneumococcal and influenza immunization and human immunodeficiency virus load in children","volume":"19","author":"Keller","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.009_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s100960100470","article-title":"Effect of pneumococcal vaccine on plasma HIV-1 RNA of stable patients undergoing effective highly active antiretroviral therapy","volume":"20","author":"Negredo","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.009_b0095","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.V86.3.1082.1082","article-title":"Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination","volume":"86","author":"O'Brien","year":"1995","journal-title":"Blood"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:07:45Z","timestamp":1717240065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X1830478X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}